Vilkeviciute, A.; Pileckaite, E.; Bruzaite, A.; Cebatoriene, D.; Gedvilaite-Vaicechauskiene, G.; Kriauciuniene, L.; Zaliuniene, D.; Liutkeviciene, R.
Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency. Medicina 2024, 60, 2072.
https://doi.org/10.3390/medicina60122072
AMA Style
Vilkeviciute A, Pileckaite E, Bruzaite A, Cebatoriene D, Gedvilaite-Vaicechauskiene G, Kriauciuniene L, Zaliuniene D, Liutkeviciene R.
Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency. Medicina. 2024; 60(12):2072.
https://doi.org/10.3390/medicina60122072
Chicago/Turabian Style
Vilkeviciute, Alvita, Enrika Pileckaite, Akvile Bruzaite, Dzastina Cebatoriene, Greta Gedvilaite-Vaicechauskiene, Loresa Kriauciuniene, Dalia Zaliuniene, and Rasa Liutkeviciene.
2024. "Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency" Medicina 60, no. 12: 2072.
https://doi.org/10.3390/medicina60122072
APA Style
Vilkeviciute, A., Pileckaite, E., Bruzaite, A., Cebatoriene, D., Gedvilaite-Vaicechauskiene, G., Kriauciuniene, L., Zaliuniene, D., & Liutkeviciene, R.
(2024). Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency. Medicina, 60(12), 2072.
https://doi.org/10.3390/medicina60122072
